UNSPSC 85582303: Supplement tongue with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement tongue with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0CU737Z

UNSPSC 85582303 Supplement tongue with autologous tissue substitute, percutaneous approach is a Commodity code that shows minimal alignment with actual state and local procurement activity. The code nominally describes a surgical procedure using autologous tissue substitutes; however, the recent opportunities posted under this code do not reflect surgical procedure procurement at all. Instead, they span independent medical evaluations, pharmacy benefit management, occupational health surveillance, surgical benefit carve-outs, specialty medical staffing, and youth detention healthcare services. None of these solicitations involve procurement of surgical devices, tissue products, or procedure-specific supplies that would fall within the code's technical definition.

The issuing bodies reflect the broad range of state and local entities active in healthcare procurement: a city retirement office (Phoenix), a county government (Collier County, Harris County), a state transportation agency (Washington Department of Transportation), a municipal health system (City of Long Beach), and a county health system (Santa Clara County). The geographic spread includes Arizona, California, Florida, Texas, and Washington across recent postings from July through September 2026. The code itself appears to be a data-entry mismatch rather than a meaningful classification for these opportunities — no vendor pursuing work under this code should expect it to surface healthcare-delivery RFPs, staffing requests, or benefit-administration contracts that happen to include surgical benefits or occupational health. This code warrants close attention only for firms specifically supplying autologous tissue products, surgical instrumentation, or procedure-related supplies directly to state and local health systems; the recent opportunity stream provides no signal of such demand.